Literature DB >> 9146558

Systematized inflammatory epidermal nevus with symmetrical involvement: an unusual case of CHILD syndrome?

R Fink-Puches1, H P Soyer, G Pierer, H Kerl, R Happle.   

Abstract

The CHILD syndrome (congenital hemidysplasia with ichthyosiform nevus and limb defects) is usually characterized by lateralization of all associated anomalies. It has been assumed that the event of X-inactivation coincides and interferes with a clone of organizer cells controlling a large developmental field. A 16-year-old girl with bilateral manifestations of CHILD syndrome is described. The inflammatory skin lesions affected the body folds (ptychotropism) in a symmetrical distribution, although only the right side of the neck was involved. In addition, absence of several facial muscles, vertebral defects, and shortening of the leg on the right side were noted, and a ventricular septum defect was present. This unusual case may be explained by the assumption that X-inactivation did not coincide with the origin of inducer cell clones controlling large morphogenetic fields on either side of the body.

Entities:  

Mesh:

Year:  1997        PMID: 9146558     DOI: 10.1016/s0190-9622(97)70031-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Congenital hemidysplasia with ichthyosiform naevus and limb defects (CHILD) syndrome without hemidysplasia.

Authors:  A Estapé; D Josifova; D Rampling; M Glover; V A Kinsler
Journal:  Br J Dermatol       Date:  2015-05-28       Impact factor: 9.302

3.  A novel NSDHL variant in CHILD syndrome with gastrointestinal manifestations and localized skin involvement.

Authors:  Ene-Choo Tan; Shi Yun Chia; Khadijah Rafi'ee; Shan Xian Lee; Andrew Boon Eu Kwek; Sze Hwa Tan; Victor Weng Leong Ng; Heming Wei; Stephanie Koo; Ai Ling Koh; Mark Jean-Aan Koh
Journal:  Mol Genet Genomic Med       Date:  2021-12-26       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.